Global Primary Hepatocytes Market Outlook 2023

Report ID: 1013901 | Published Date: Sep 2024 | No. of Page: 130 | Base Year: 2023 | Rating: 4 | Webstory: Check our Web story
1 Primary Hepatocytes Market Overview
    1.1 Product Overview and Scope of Primary Hepatocytes
    1.2 Primary Hepatocytes Segment by Type
        1.2.1 Global Primary Hepatocytes Sales Growth Rate Comparison by Type (2021-2027)
        1.2.2 Human Primary Cells
        1.2.3 Animal Primary Cells
    1.3 Primary Hepatocytes Segment by Application
        1.3.1 Global Primary Hepatocytes Sales Comparison by Application: (2021-2027)
        1.3.2 Life Science Research Companies
        1.3.3 Research Institutes
        1.3.4 Others
    1.4 Global Primary Hepatocytes Market Size Estimates and Forecasts
        1.4.1 Global Primary Hepatocytes Revenue 2016-2027
        1.4.2 Global Primary Hepatocytes Sales 2016-2027
        1.4.3 Primary Hepatocytes Market Size by Region: 2016 Versus 2021 Versus 2027

2 Primary Hepatocytes Market Competition by Manufacturers
    2.1 Global Primary Hepatocytes Sales Market Share by Manufacturers (2016-2021)
    2.2 Global Primary Hepatocytes Revenue Market Share by Manufacturers (2016-2021)
    2.3 Global Primary Hepatocytes Average Price by Manufacturers (2016-2021)
    2.4 Manufacturers Primary Hepatocytes Manufacturing Sites, Area Served, Product Type
    2.5 Primary Hepatocytes Market Competitive Situation and Trends
        2.5.1 Primary Hepatocytes Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Primary Hepatocytes Players Market Share by Revenue
        2.5.3 Global Primary Hepatocytes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Primary Hepatocytes Retrospective Market Scenario by Region
    3.1 Global Primary Hepatocytes Retrospective Market Scenario in Sales by Region: 2016-2021
    3.2 Global Primary Hepatocytes Retrospective Market Scenario in Revenue by Region: 2016-2021
    3.3 North America Primary Hepatocytes Market Facts & Figures by Country
        3.3.1 North America Primary Hepatocytes Sales by Country
        3.3.2 North America Primary Hepatocytes Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Primary Hepatocytes Market Facts & Figures by Country
        3.4.1 Europe Primary Hepatocytes Sales by Country
        3.4.2 Europe Primary Hepatocytes Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Primary Hepatocytes Market Facts & Figures by Region
        3.5.1 Asia Pacific Primary Hepatocytes Sales by Region
        3.5.2 Asia Pacific Primary Hepatocytes Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Primary Hepatocytes Market Facts & Figures by Country
        3.6.1 Latin America Primary Hepatocytes Sales by Country
        3.6.2 Latin America Primary Hepatocytes Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Primary Hepatocytes Market Facts & Figures by Country
        3.7.1 Middle East and Africa Primary Hepatocytes Sales by Country
        3.7.2 Middle East and Africa Primary Hepatocytes Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Primary Hepatocytes Historic Market Analysis by Type
    4.1 Global Primary Hepatocytes Sales Market Share by Type (2016-2021)
    4.2 Global Primary Hepatocytes Revenue Market Share by Type (2016-2021)
    4.3 Global Primary Hepatocytes Price by Type (2016-2021)

5 Global Primary Hepatocytes Historic Market Analysis by Application
    5.1 Global Primary Hepatocytes Sales Market Share by Application (2016-2021)
    5.2 Global Primary Hepatocytes Revenue Market Share by Application (2016-2021)
    5.3 Global Primary Hepatocytes Price by Application (2016-2021)

6 Key Companies Profiled
    6.1 Thermo Fisher Scientific, Inc.
        6.1.1 Thermo Fisher Scientific, Inc. Corporation Information
        6.1.2 Thermo Fisher Scientific, Inc. Description and Business Overview
        6.1.3 Thermo Fisher Scientific, Inc. Primary Hepatocytes Sales, Revenue and Gross Margin (2016-2021)
        6.1.4 Thermo Fisher Scientific, Inc. Primary Hepatocytes Product Portfolio
        6.1.5 Thermo Fisher Scientific, Inc. Recent Developments/Updates
    6.2 Merck KGaA
        6.2.1 Merck KGaA Corporation Information
        6.2.2 Merck KGaA Description and Business Overview
        6.2.3 Merck KGaA Primary Hepatocytes Sales, Revenue and Gross Margin (2016-2021)
        6.2.4 Merck KGaA Primary Hepatocytes Product Portfolio
        6.2.5 Merck KGaA Recent Developments/Updates
    6.3 Lonza
        6.3.1 Lonza Corporation Information
        6.3.2 Lonza Description and Business Overview
        6.3.3 Lonza Primary Hepatocytes Sales, Revenue and Gross Margin (2016-2021)
        6.3.4 Lonza Primary Hepatocytes Product Portfolio
        6.3.5 Lonza Recent Developments/Updates
    6.4 Cell Biologics, Inc.
        6.4.1 Cell Biologics, Inc. Corporation Information
        6.4.2 Cell Biologics, Inc. Description and Business Overview
        6.4.3 Cell Biologics, Inc. Primary Hepatocytes Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Cell Biologics, Inc. Primary Hepatocytes Product Portfolio
        6.4.5 Cell Biologics, Inc. Recent Developments/Updates
    6.5 PromoCell GmbH
        6.5.1 PromoCell GmbH Corporation Information
        6.5.2 PromoCell GmbH Description and Business Overview
        6.5.3 PromoCell GmbH Primary Hepatocytes Sales, Revenue and Gross Margin (2016-2021)
        6.5.4 PromoCell GmbH Primary Hepatocytes Product Portfolio
        6.5.5 PromoCell GmbH Recent Developments/Updates
    6.6 HemaCare Corporation
        6.6.1 HemaCare Corporation Corporation Information
        6.6.2 HemaCare Corporation Description and Business Overview
        6.6.3 HemaCare Corporation Primary Hepatocytes Sales, Revenue and Gross Margin (2016-2021)
        6.6.4 HemaCare Corporation Primary Hepatocytes Product Portfolio
        6.6.5 HemaCare Corporation Recent Developments/Updates
    6.7 ZenBio, Inc.
        6.6.1 ZenBio, Inc. Corporation Information
        6.6.2 ZenBio, Inc. Description and Business Overview
        6.6.3 ZenBio, Inc. Primary Hepatocytes Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 ZenBio, Inc. Primary Hepatocytes Product Portfolio
        6.7.5 ZenBio, Inc. Recent Developments/Updates
    6.8 STEMCELL Technologies, Inc.
        6.8.1 STEMCELL Technologies, Inc. Corporation Information
        6.8.2 STEMCELL Technologies, Inc. Description and Business Overview
        6.8.3 STEMCELL Technologies, Inc. Primary Hepatocytes Sales, Revenue and Gross Margin (2016-2021)
        6.8.4 STEMCELL Technologies, Inc. Primary Hepatocytes Product Portfolio
        6.8.5 STEMCELL Technologies, Inc. Recent Developments/Updates
    6.9 Corning Incorporated
        6.9.1 Corning Incorporated Corporation Information
        6.9.2 Corning Incorporated Description and Business Overview
        6.9.3 Corning Incorporated Primary Hepatocytes Sales, Revenue and Gross Margin (2016-2021)
        6.9.4 Corning Incorporated Primary Hepatocytes Product Portfolio
        6.9.5 Corning Incorporated Recent Developments/Updates
    6.10 AllCells
        6.10.1 AllCells Corporation Information
        6.10.2 AllCells Description and Business Overview
        6.10.3 AllCells Primary Hepatocytes Sales, Revenue and Gross Margin (2016-2021)
        6.10.4 AllCells Primary Hepatocytes Product Portfolio
        6.10.5 AllCells Recent Developments/Updates
    6.11 Axol Bioscience Ltd.
        6.11.1 Axol Bioscience Ltd. Corporation Information
        6.11.2 Axol Bioscience Ltd. Primary Hepatocytes Description and Business Overview
        6.11.3 Axol Bioscience Ltd. Primary Hepatocytes Sales, Revenue and Gross Margin (2016-2021)
        6.11.4 Axol Bioscience Ltd. Primary Hepatocytes Product Portfolio
        6.11.5 Axol Bioscience Ltd. Recent Developments/Updates
    6.12 iXCells Biotechnologies
        6.12.1 iXCells Biotechnologies Corporation Information
        6.12.2 iXCells Biotechnologies Primary Hepatocytes Description and Business Overview
        6.12.3 iXCells Biotechnologies Primary Hepatocytes Sales, Revenue and Gross Margin (2016-2021)
        6.12.4 iXCells Biotechnologies Primary Hepatocytes Product Portfolio
        6.12.5 iXCells Biotechnologies Recent Developments/Updates
    6.13 Neuromics
        6.13.1 Neuromics Corporation Information
        6.13.2 Neuromics Primary Hepatocytes Description and Business Overview
        6.13.3 Neuromics Primary Hepatocytes Sales, Revenue and Gross Margin (2016-2021)
        6.13.4 Neuromics Primary Hepatocytes Product Portfolio
        6.13.5 Neuromics Recent Developments/Updates
    6.14 StemExpress
        6.14.1 StemExpress Corporation Information
        6.14.2 StemExpress Primary Hepatocytes Description and Business Overview
        6.14.3 StemExpress Primary Hepatocytes Sales, Revenue and Gross Margin (2016-2021)
        6.14.4 StemExpress Primary Hepatocytes Product Portfolio
        6.14.5 StemExpress Recent Developments/Updates
    6.15 BioIVT
        6.15.1 BioIVT Corporation Information
        6.15.2 BioIVT Primary Hepatocytes Description and Business Overview
        6.15.3 BioIVT Primary Hepatocytes Sales, Revenue and Gross Margin (2016-2021)
        6.15.4 BioIVT Primary Hepatocytes Product Portfolio
        6.15.5 BioIVT Recent Developments/Updates
    6.16 ScienCell Research Laboratories, Inc.
        6.16.1 ScienCell Research Laboratories, Inc. Corporation Information
        6.16.2 ScienCell Research Laboratories, Inc. Primary Hepatocytes Description and Business Overview
        6.16.3 ScienCell Research Laboratories, Inc. Primary Hepatocytes Sales, Revenue and Gross Margin (2016-2021)
        6.16.4 ScienCell Research Laboratories, Inc. Primary Hepatocytes Product Portfolio
        6.16.5 ScienCell Research Laboratories, Inc. Recent Developments/Updates
    6.17 PPA Research Group, Inc.
        6.17.1 PPA Research Group, Inc. Corporation Information
        6.17.2 PPA Research Group, Inc. Primary Hepatocytes Description and Business Overview
        6.17.3 PPA Research Group, Inc. Primary Hepatocytes Sales, Revenue and Gross Margin (2016-2021)
        6.17.4 PPA Research Group, Inc. Primary Hepatocytes Product Portfolio
        6.17.5 PPA Research Group, Inc. Recent Developments/Updates
    6.18 Creative Bioarray
        6.18.1 Creative Bioarray Corporation Information
        6.18.2 Creative Bioarray Primary Hepatocytes Description and Business Overview
        6.18.3 Creative Bioarray Primary Hepatocytes Sales, Revenue and Gross Margin (2016-2021)
        6.18.4 Creative Bioarray Primary Hepatocytes Product Portfolio
        6.18.5 Creative Bioarray Recent Developments/Updates
    6.19 BPS Bioscience, Inc.
        6.19.1 BPS Bioscience, Inc. Corporation Information
        6.19.2 BPS Bioscience, Inc. Primary Hepatocytes Description and Business Overview
        6.19.3 BPS Bioscience, Inc. Primary Hepatocytes Sales, Revenue and Gross Margin (2016-2021)
        6.19.4 BPS Bioscience, Inc. Primary Hepatocytes Product Portfolio
        6.19.5 BPS Bioscience, Inc. Recent Developments/Updates
    6.20 Epithelix Sàrl
        6.20.1 Epithelix Sàrl Corporation Information
        6.20.2 Epithelix Sàrl Primary Hepatocytes Description and Business Overview
        6.20.3 Epithelix Sàrl Primary Hepatocytes Sales, Revenue and Gross Margin (2016-2021)
        6.20.4 Epithelix Sàrl Primary Hepatocytes Product Portfolio
        6.20.5 Epithelix Sàrl Recent Developments/Updates
    6.21 ReachBio LLC
        6.21.1 ReachBio LLC Corporation Information
        6.21.2 ReachBio LLC Primary Hepatocytes Description and Business Overview
        6.21.3 ReachBio LLC Primary Hepatocytes Sales, Revenue and Gross Margin (2016-2021)
        6.21.4 ReachBio LLC Primary Hepatocytes Product Portfolio
        6.21.5 ReachBio LLC Recent Developments/Updates
    6.22 AcceGen
        6.22.1 AcceGen Corporation Information
        6.22.2 AcceGen Primary Hepatocytes Description and Business Overview
        6.22.3 AcceGen Primary Hepatocytes Sales, Revenue and Gross Margin (2016-2021)
        6.22.4 AcceGen Primary Hepatocytes Product Portfolio
        6.22.5 AcceGen Recent Developments/Updates
    6.23 Sekisui XenoTech, LLC
        6.23.1 Sekisui XenoTech, LLC Corporation Information
        6.23.2 Sekisui XenoTech, LLC Primary Hepatocytes Description and Business Overview
        6.23.3 Sekisui XenoTech, LLC Primary Hepatocytes Sales, Revenue and Gross Margin (2016-2021)
        6.23.4 Sekisui XenoTech, LLC Primary Hepatocytes Product Portfolio
        6.23.5 Sekisui XenoTech, LLC Recent Developments/Updates
    6.24 Biopredic International
        6.24.1 Biopredic International Corporation Information
        6.24.2 Biopredic International Primary Hepatocytes Description and Business Overview
        6.24.3 Biopredic International Primary Hepatocytes Sales, Revenue and Gross Margin (2016-2021)
        6.24.4 Biopredic International Primary Hepatocytes Product Portfolio
        6.24.5 Biopredic International Recent Developments/Updates

7 Primary Hepatocytes Manufacturing Cost Analysis
    7.1 Primary Hepatocytes Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Primary Hepatocytes
    7.4 Primary Hepatocytes Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Primary Hepatocytes Distributors List
    8.3 Primary Hepatocytes Customers

9 Primary Hepatocytes Market Dynamics
    9.1 Primary Hepatocytes Industry Trends
    9.2 Primary Hepatocytes Growth Drivers
    9.3 Primary Hepatocytes Market Challenges
    9.4 Primary Hepatocytes Market Restraints

10 Global Market Forecast
    10.1 Primary Hepatocytes Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Primary Hepatocytes by Type (2022-2027)
        10.1.2 Global Forecasted Revenue of Primary Hepatocytes by Type (2022-2027)
    10.2 Primary Hepatocytes Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Primary Hepatocytes by Application (2022-2027)
        10.2.2 Global Forecasted Revenue of Primary Hepatocytes by Application (2022-2027)
    10.3 Primary Hepatocytes Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Primary Hepatocytes by Region (2022-2027)
        10.3.2 Global Forecasted Revenue of Primary Hepatocytes by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer
List of Tables
    Table 1. Global Primary Hepatocytes Sales (K Units) Growth Rate Comparison by Type (2021-2027)
    Table 2. Global Primary Hepatocytes Sales (K Units) Comparison by Application (2021-2027)
    Table 3. Global Primary Hepatocytes Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
    Table 4. Key Manufacturers Primary Hepatocytes Covered in This Study
    Table 5. Global Primary Hepatocytes Sales (K Units) of Key Manufacturers (2016-2021)
    Table 6. Global Primary Hepatocytes Sales Market Share by Manufacturers (2016-2021)
    Table 7. Global Primary Hepatocytes Revenue (US$ Million) by Manufacturers (2016-2021)
    Table 8. Global Primary Hepatocytes Revenue Share by Manufacturers (2016-2021)
    Table 9. Global Market Primary Hepatocytes Average Price (US$/Unit) of Key Manufacturers (2016-2021)
    Table 10. Manufacturers Primary Hepatocytes Manufacturing Sites and Area Served
    Table 11. Manufacturers Primary Hepatocytes Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Primary Hepatocytes by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Primary Hepatocytes as of 2020)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Primary Hepatocytes Sales by Region (2016-2021) & (K Units)
    Table 16. Global Primary Hepatocytes Sales Market Share by Region (2016-2021)
    Table 17. Global Primary Hepatocytes Revenue by Region (2016-2021) & (US$ Million)
    Table 18. North America Primary Hepatocytes Sales by Country (2016-2021) & (K Units)
    Table 19. North America Primary Hepatocytes Sales Market Share by Country (2016-2021)
    Table 20. North America Primary Hepatocytes Revenue by Country (2016-2021) & (US$ Million)
    Table 21. North America Primary Hepatocytes Revenue Market Share by Country (2016-2021)
    Table 22. Europe Primary Hepatocytes Sales by Country (2016-2021) & (K Units)
    Table 23. Europe Primary Hepatocytes Sales Market Share by Country (2016-2021)
    Table 24. Europe Primary Hepatocytes Revenue by Country (2016-2021) & (US$ Million)
    Table 25. Europe Primary Hepatocytes Revenue Market Share by Country (2016-2021)
    Table 26. Asia Pacific Primary Hepatocytes Sales by Region (2016-2021) & (K Units)
    Table 27. Asia Pacific Primary Hepatocytes Sales Market Share by Region (2016-2021)
    Table 28. Asia Pacific Primary Hepatocytes Revenue by Region (2016-2021) & (US$ Million)
    Table 29. Asia Pacific Primary Hepatocytes Revenue Market Share by Region (2016-2021)
    Table 30. Latin America Primary Hepatocytes Sales by Country (2016-2021) & (K Units)
    Table 31. Latin America Primary Hepatocytes Sales Market Share by Country (2016-2021)
    Table 32. Latin America Primary Hepatocytes Revenue by Country (2016-2021) & (US$ Million)
    Table 33. Latin America Primary Hepatocytes Revenue Market Share by Country (2016-2021)
    Table 34. Middle East and Africa Primary Hepatocytes Sales by Country (2016-2021) & (K Units)
    Table 35. Middle East and Africa Primary Hepatocytes Sales Market Share by Country (2016-2021)
    Table 36. Middle East and Africa Primary Hepatocytes Revenue by Country (2016-2021) & (US$ Million)
    Table 37. Middle East and Africa Primary Hepatocytes Revenue Market Share by Country (2016-2021)
    Table 38. Global Primary Hepatocytes Sales (K Units) by Type (2016-2021)
    Table 39. Global Primary Hepatocytes Sales Market Share by Type (2016-2021)
    Table 40. Global Primary Hepatocytes Revenue (Million US$) by Type (2016-2021)
    Table 41. Global Primary Hepatocytes Revenue Share by Type (2016-2021)
    Table 42. Global Primary Hepatocytes Price (US$/Unit) by Type (2016-2021)
    Table 43. Global Primary Hepatocytes Sales (K Units) by Application (2016-2021)
    Table 44. Global Primary Hepatocytes Sales Market Share by Application (2016-2021)
    Table 45. Global Primary Hepatocytes Revenue (Million US$) by Application (2016-2021)
    Table 46. Global Primary Hepatocytes Revenue Share by Application (2016-2021)
    Table 47. Global Primary Hepatocytes Price (US$/Unit) by Application (2016-2021)
    Table 48. Thermo Fisher Scientific, Inc. Corporation Information
    Table 49. Thermo Fisher Scientific, Inc. Description and Business Overview
    Table 50. Thermo Fisher Scientific, Inc. Primary Hepatocytes Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 51. Thermo Fisher Scientific, Inc. Primary Hepatocytes Product
    Table 52. Thermo Fisher Scientific, Inc. Recent Developments/Updates
    Table 53. Merck KGaA Corporation Information
    Table 54. Merck KGaA Description and Business Overview
    Table 55. Merck KGaA Primary Hepatocytes Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 56. Merck KGaA Primary Hepatocytes Product
    Table 57. Merck KGaA Recent Developments/Updates
    Table 58. Lonza Corporation Information
    Table 59. Lonza Description and Business Overview
    Table 60. Lonza Primary Hepatocytes Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 61. Lonza Primary Hepatocytes Product
    Table 62. Lonza Recent Developments/Updates
    Table 63. Cell Biologics, Inc. Corporation Information
    Table 64. Cell Biologics, Inc. Description and Business Overview
    Table 65. Cell Biologics, Inc. Primary Hepatocytes Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 66. Cell Biologics, Inc. Primary Hepatocytes Product
    Table 67. Cell Biologics, Inc. Recent Developments/Updates
    Table 68. PromoCell GmbH Corporation Information
    Table 69. PromoCell GmbH Description and Business Overview
    Table 70. PromoCell GmbH Primary Hepatocytes Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 71. PromoCell GmbH Primary Hepatocytes Product
    Table 72. PromoCell GmbH Recent Developments/Updates
    Table 73. HemaCare Corporation Corporation Information
    Table 74. HemaCare Corporation Description and Business Overview
    Table 75. HemaCare Corporation Primary Hepatocytes Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 76. HemaCare Corporation Primary Hepatocytes Product
    Table 77. HemaCare Corporation Recent Developments/Updates
    Table 78. ZenBio, Inc. Corporation Information
    Table 79. ZenBio, Inc. Description and Business Overview
    Table 80. ZenBio, Inc. Primary Hepatocytes Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 81. ZenBio, Inc. Primary Hepatocytes Product
    Table 82. ZenBio, Inc. Recent Developments/Updates
    Table 83. STEMCELL Technologies, Inc. Corporation Information
    Table 84. STEMCELL Technologies, Inc. Description and Business Overview
    Table 85. STEMCELL Technologies, Inc. Primary Hepatocytes Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 86. STEMCELL Technologies, Inc. Primary Hepatocytes Product
    Table 87. STEMCELL Technologies, Inc. Recent Developments/Updates
    Table 88. Corning Incorporated Corporation Information
    Table 89. Corning Incorporated Description and Business Overview
    Table 90. Corning Incorporated Primary Hepatocytes Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 91. Corning Incorporated Primary Hepatocytes Product
    Table 92. Corning Incorporated Recent Developments/Updates
    Table 93. AllCells Corporation Information
    Table 94. AllCells Description and Business Overview
    Table 95. AllCells Primary Hepatocytes Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 96. AllCells Primary Hepatocytes Product
    Table 97. AllCells Recent Developments/Updates
    Table 98. Axol Bioscience Ltd. Corporation Information
    Table 99. Axol Bioscience Ltd. Description and Business Overview
    Table 100. Axol Bioscience Ltd. Primary Hepatocytes Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 101. Axol Bioscience Ltd. Primary Hepatocytes Product
    Table 102. Axol Bioscience Ltd. Recent Developments/Updates
    Table 103. iXCells Biotechnologies Corporation Information
    Table 104. iXCells Biotechnologies Description and Business Overview
    Table 105. iXCells Biotechnologies Primary Hepatocytes Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 106. iXCells Biotechnologies Primary Hepatocytes Product
    Table 107. iXCells Biotechnologies Recent Developments/Updates
    Table 108. Neuromics Corporation Information
    Table 109. Neuromics Description and Business Overview
    Table 110. Neuromics Primary Hepatocytes Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 111. Neuromics Primary Hepatocytes Product
    Table 112. Neuromics Recent Developments/Updates
    Table 113. StemExpress Corporation Information
    Table 114. StemExpress Description and Business Overview
    Table 115. StemExpress Primary Hepatocytes Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 116. StemExpress Primary Hepatocytes Product
    Table 117. StemExpress Recent Developments/Updates
    Table 118. BioIVT Corporation Information
    Table 119. BioIVT Description and Business Overview
    Table 120. BioIVT Primary Hepatocytes Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 121. BioIVT Primary Hepatocytes Product
    Table 122. BioIVT Recent Developments/Updates
    Table 123. ScienCell Research Laboratories, Inc. Corporation Information
    Table 124. ScienCell Research Laboratories, Inc. Description and Business Overview
    Table 125. ScienCell Research Laboratories, Inc. Primary Hepatocytes Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 126. ScienCell Research Laboratories, Inc. Primary Hepatocytes Product
    Table 127. ScienCell Research Laboratories, Inc. Recent Developments/Updates
    Table 128. PPA Research Group, Inc. Corporation Information
    Table 129. PPA Research Group, Inc. Description and Business Overview
    Table 130. PPA Research Group, Inc. Primary Hepatocytes Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 131. PPA Research Group, Inc. Primary Hepatocytes Product
    Table 132. PPA Research Group, Inc. Recent Developments/Updates
    Table 133. Creative Bioarray Corporation Information
    Table 134. Creative Bioarray Description and Business Overview
    Table 135. Creative Bioarray Primary Hepatocytes Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 136. Creative Bioarray Primary Hepatocytes Product
    Table 137. Creative Bioarray Recent Developments/Updates
    Table 138. BPS Bioscience, Inc. Corporation Information
    Table 139. BPS Bioscience, Inc. Description and Business Overview
    Table 140. BPS Bioscience, Inc. Primary Hepatocytes Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 141. BPS Bioscience, Inc. Primary Hepatocytes Product
    Table 142. BPS Bioscience, Inc. Recent Developments/Updates
    Table 143. Epithelix Sàrl Corporation Information
    Table 144. Epithelix Sàrl Description and Business Overview
    Table 145. Epithelix Sàrl Primary Hepatocytes Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 146. Epithelix Sàrl Primary Hepatocytes Product
    Table 147. Epithelix Sàrl Recent Developments/Updates
    Table 148. ReachBio LLC Corporation Information
    Table 149. ReachBio LLC Description and Business Overview
    Table 150. ReachBio LLC Primary Hepatocytes Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 151. ReachBio LLC Primary Hepatocytes Product
    Table 152. ReachBio LLC Recent Developments/Updates
    Table 153. AcceGen Corporation Information
    Table 154. AcceGen Description and Business Overview
    Table 155. AcceGen Primary Hepatocytes Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 156. AcceGen Primary Hepatocytes Product
    Table 157. AcceGen Recent Developments/Updates
    Table 158. Sekisui XenoTech, LLC Corporation Information
    Table 159. Sekisui XenoTech, LLC Description and Business Overview
    Table 160. Sekisui XenoTech, LLC Primary Hepatocytes Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 161. Sekisui XenoTech, LLC Primary Hepatocytes Product
    Table 162. Sekisui XenoTech, LLC Recent Developments/Updates
    Table 163. Biopredic International Corporation Information
    Table 164. Biopredic International Description and Business Overview
    Table 165. Biopredic International Primary Hepatocytes Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 166. Biopredic International Primary Hepatocytes Product
    Table 167. Biopredic International Recent Developments/Updates
    Table 168. Production Base and Market Concentration Rate of Raw Material
    Table 169. Key Suppliers of Raw Materials
    Table 170. Primary Hepatocytes Distributors List
    Table 171. Primary Hepatocytes Customers List
    Table 172. Primary Hepatocytes Market Trends
    Table 173. Primary Hepatocytes Growth Drivers
    Table 174. Primary Hepatocytes Market Challenges
    Table 175. Primary Hepatocytes Market Restraints
    Table 176. Global Primary Hepatocytes Sales Forecast by Type (2022-2027) & (K Units)
    Table 177. Global Primary Hepatocytes Sales Market Share Forecast by Type (2022-2027)
    Table 178. Global Primary Hepatocytes Revenue Forecast by Type (2022-2027) & (US$ Million)
    Table 179. Global Primary Hepatocytes Revenue Market Share Forecast by Type (2022-2027)
    Table 180. Global Primary Hepatocytes Sales Forecast by Application (2022-2027) & (K Units)
    Table 181. Global Primary Hepatocytes Sales Market Share Forecast by Application (2022-2027)
    Table 182. Global Primary Hepatocytes Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 183. Global Primary Hepatocytes Revenue Market Share Forecast by Application (2022-2027)
    Table 184. Global Primary Hepatocytes Sales Forecast by Region (2022-2027) & (K Units)
    Table 185. Global Primary Hepatocytes Sales Market Share Forecast by Region (2022-2027)
    Table 186. Global Primary Hepatocytes Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 187. Global Primary Hepatocytes Revenue Market Share Forecast by Region (2022-2027)
    Table 188. Research Programs/Design for This Report
    Table 189. Key Data Information from Secondary Sources
    Table 190. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Primary Hepatocytes
    Figure 2. Global Primary Hepatocytes Market Share by Type in 2020 & 2027
    Figure 3. Human Primary Cells Product Picture
    Figure 4. Animal Primary Cells Product Picture
    Figure 5. Global Primary Hepatocytes Market Share by Application in 2020 & 2027
    Figure 6. Life Science Research Companies
    Figure 7. Research Institutes
    Figure 8. Others
    Figure 9. Global Primary Hepatocytes Revenue, (US$ Million), 2016 VS 2021 VS 2027
    Figure 10. Global Primary Hepatocytes Market Size 2016-2027 (US$ Million)
    Figure 11. Global Primary Hepatocytes Sales 2016-2027 (K Units)
    Figure 12. Global Primary Hepatocytes Market Size Market Share by Region: 2016 VS 20210 VS 2027
    Figure 13. Primary Hepatocytes Sales Share by Manufacturers in 2020
    Figure 14. Global Primary Hepatocytes Revenue Share by Manufacturers in 2020
    Figure 15. The Global 5 and 10 Largest Primary Hepatocytes Players: Market Share by Revenue in 2020
    Figure 16. Primary Hepatocytes Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
    Figure 17. Global Primary Hepatocytes Sales Market Share by Region (2016-2021)
    Figure 18. Global Primary Hepatocytes Sales Market Share by Region in 2020
    Figure 19. Global Primary Hepatocytes Revenue Market Share by Region (2016-2021)
    Figure 20. Global Primary Hepatocytes Revenue Market Share by Region in 2020
    Figure 21. U.S. Primary Hepatocytes Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 22. Canada Primary Hepatocytes Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 23. Germany Primary Hepatocytes Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 24. France Primary Hepatocytes Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 25. U.K. Primary Hepatocytes Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 26. Italy Primary Hepatocytes Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 27. Russia Primary Hepatocytes Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 28. China Primary Hepatocytes Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 29. Japan Primary Hepatocytes Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 30. South Korea Primary Hepatocytes Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 31. India Primary Hepatocytes Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 32. Australia Primary Hepatocytes Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 33. Taiwan Primary Hepatocytes Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 34. Indonesia Primary Hepatocytes Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 35. Thailand Primary Hepatocytes Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 36. Malaysia Primary Hepatocytes Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 37. Philippines Primary Hepatocytes Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 38. Vietnam Primary Hepatocytes Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 39. Mexico Primary Hepatocytes Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 40. Brazil Primary Hepatocytes Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 41. Argentina Primary Hepatocytes Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 42. Turkey Primary Hepatocytes Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 43. Saudi Arabia Primary Hepatocytes Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 44. UAE Primary Hepatocytes Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 45. Sales Market Share of Primary Hepatocytes by Type (2016-2021)
    Figure 46. Sales Market Share of Primary Hepatocytes by Application (2016-2021)
    Figure 47. Sales Market Share of Primary Hepatocytes by Application in 2020
    Figure 48. Revenue Share of Primary Hepatocytes by Application (2016-2021)
    Figure 49. Revenue Share of Primary Hepatocytes by Application in 2020
    Figure 50. Manufacturing Cost Structure of Primary Hepatocytes
    Figure 51. Manufacturing Process Analysis of Primary Hepatocytes
    Figure 52. Primary Hepatocytes Industrial Chain Analysis
    Figure 53. Channels of Distribution
    Figure 54. Distributors Profiles
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
    Figure 57. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Thermo Fisher Scientific, Inc.
Merck KGaA
Lonza
Cell Biologics, Inc.
PromoCell GmbH
HemaCare Corporation
ZenBio, Inc.
STEMCELL Technologies, Inc.
Corning Incorporated
AllCells
Axol Bioscience Ltd.
iXCells Biotechnologies
Neuromics
StemExpress
BioIVT
ScienCell Research Laboratories, Inc.
PPA Research Group, Inc.
Creative Bioarray
BPS Bioscience, Inc.
Epithelix Sàrl
ReachBio LLC
AcceGen
Sekisui XenoTech, LLC
Biopredic International
Frequently Asked Questions
Primary Hepatocytes report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Primary Hepatocytes report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Primary Hepatocytes report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Ethyl Bromopyruvate

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More